Abstract
Recent years have witnessed numerous attempts at identifying the biological correlates of impending psychosis. Biochemical markers may theoretically provide a powerful approach to identify at-risk individuals, potentially leading to more effective intervention strategies to treat them. Hopefully, future developments in the field of research biochemistry in patients with at risk mental states or prodromal symptoms will make this approach ideal for screening and monitoring purposes. In this review, we provide an overview of the different biochemical markers which have been recently demonstrated to be altered in the biological fluids of patients with impending psychosis. We will also examine the practical issues that seem to be limiting the effective integration of biomarkers into clinical development.
Keywords: Biomarkers, at risk mental states, prodromal symptoms, psychosis, neurotrophins, oxidative stress, cannabinoids, schizophrenia, Mass spectrometry, cytokines
Current Pharmaceutical Design
Title: Biochemical Markers of Impending Psychosis
Volume: 18 Issue: 4
Author(s): Enzo Emanuele, Valentina Martinelli, Vera Abbiati, Paolo Fusar-Poli and Pierluigi Politi
Affiliation:
Keywords: Biomarkers, at risk mental states, prodromal symptoms, psychosis, neurotrophins, oxidative stress, cannabinoids, schizophrenia, Mass spectrometry, cytokines
Abstract: Recent years have witnessed numerous attempts at identifying the biological correlates of impending psychosis. Biochemical markers may theoretically provide a powerful approach to identify at-risk individuals, potentially leading to more effective intervention strategies to treat them. Hopefully, future developments in the field of research biochemistry in patients with at risk mental states or prodromal symptoms will make this approach ideal for screening and monitoring purposes. In this review, we provide an overview of the different biochemical markers which have been recently demonstrated to be altered in the biological fluids of patients with impending psychosis. We will also examine the practical issues that seem to be limiting the effective integration of biomarkers into clinical development.
Export Options
About this article
Cite this article as:
Emanuele Enzo, Martinelli Valentina, Abbiati Vera, Fusar-Poli Paolo and Politi Pierluigi, Biochemical Markers of Impending Psychosis, Current Pharmaceutical Design 2012; 18 (4) . https://dx.doi.org/10.2174/138161212799316000
DOI https://dx.doi.org/10.2174/138161212799316000 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Stent Thrombosis and Duration of Dual Antiplatelet Therapy
Current Pharmaceutical Design HClO4-SiO2 and NaHSO4-SiO2: Two Efficient Heterogeneous Catalysts for Synthesis of N-Acylsulfonamides under Solvent-free Conditions
Letters in Organic Chemistry Role of the NF-kB Pathway in the Pathogenesis of Human Disease States
Current Molecular Medicine Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets Biological Markers in Older People at Risk of Mobility Limitations
Current Pharmaceutical Design The Anti Inflammatory Effects of High Density Lipoproteins
Current Medicinal Chemistry Preface
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Nuclear Factor Kappa B is a Promising Therapeutic Target in Inflammatory Lung Disease
Current Drug Targets Non-Steroidal Anti-Inflammatory Drugs Loaded Liposomes for Topical Treatment of Inflammatory and Degenerative Conditions
Current Medicinal Chemistry Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine Adipose Derived Stem Cells for Musculoskeletal Regeneration: Recent Patents and Future Perspectives
Recent Patents on Regenerative Medicine Angiogenesis in Osteoarthritis
Current Rheumatology Reviews Targeted Renal Delivery of Protein Kinase Inhibitors for the Treatment of Chronic Kidney Disease
Current Signal Transduction Therapy Parallel and Multiplexed Bead-Based Assays and Encoding Strategies
Combinatorial Chemistry & High Throughput Screening Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health
Current Medicinal Chemistry Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update
Reviews on Recent Clinical Trials Recent Knowledge and New Pharmaceutical Products in Potential Alleviation of Endometriosis
Recent Patents on Inflammation & Allergy Drug Discovery Efflux Pumps in Drug Resistance of Candida
Infectious Disorders - Drug Targets The Effect of Denatured Flagellin on Toll-Like Receptor-5 (TLR-5) in Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets